Medical Device Regulations
IMG_Apr272021at24152PM.jpg
DiabetesFractyl’s Latest Milestone: Breakthrough Device DesignationFractyl’s Latest Milestone: Breakthrough Device Designation
The Lexington, MA-based company is developing a therapy that uses ablation to ablate a portion of the duodenum mucosa, which could have the potential to improve glucose control in patients struggling to manage diabetes.
Sign up for the QMED & MD+DI Daily newsletter.